LAULETTA, GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 940
NA - Nord America 537
EU - Europa 394
SA - Sud America 110
Continente sconosciuto - Info sul continente non disponibili 31
AF - Africa 18
Totale 2.030
Nazione #
US - Stati Uniti d'America 504
SG - Singapore 355
RU - Federazione Russa 211
CN - Cina 208
VN - Vietnam 179
BR - Brasile 90
IT - Italia 62
DE - Germania 53
HK - Hong Kong 46
IN - India 35
JP - Giappone 31
BD - Bangladesh 30
KR - Corea 24
FR - Francia 23
CA - Canada 14
MX - Messico 11
AR - Argentina 9
ES - Italia 8
GB - Regno Unito 8
PH - Filippine 7
AT - Austria 5
EC - Ecuador 5
FI - Finlandia 5
NL - Olanda 5
TH - Thailandia 5
MA - Marocco 4
ZA - Sudafrica 4
CO - Colombia 3
DZ - Algeria 3
ID - Indonesia 3
IQ - Iraq 3
JM - Giamaica 3
PL - Polonia 3
UA - Ucraina 3
CI - Costa d'Avorio 2
IE - Irlanda 2
LT - Lituania 2
PK - Pakistan 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
MR - Mauritania 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
SE - Svezia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
TZ - Tanzania 1
UZ - Uzbekistan 1
Totale 2.000
Città #
Singapore 190
San Jose 162
Hefei 90
Moscow 62
Ho Chi Minh City 58
Ashburn 56
Hanoi 44
Hong Kong 44
Santa Clara 44
Beijing 41
Tokyo 28
New York 20
Kochi 18
Los Angeles 17
Seoul 17
Lauterbourg 15
Council Bluffs 12
Munich 12
Rome 12
Dallas 11
Milan 10
The Dalles 9
Nuremberg 8
São Paulo 8
Frankfurt am Main 7
Redondo Beach 7
Buffalo 6
Chennai 6
Haiphong 6
Mexico City 6
Naples 6
Schoenwalde 5
Toronto 5
Turin 5
Vienna 5
Arezzo 4
Atlanta 4
Da Nang 4
Don Benito 4
Montreal 4
Phủ Lý 4
Poplar 4
Biên Hòa 3
Bologna 3
Chicago 3
Falkenstein 3
Helsinki 3
Houston 3
Medellín 3
New Delhi 3
Philadelphia 3
Quito 3
Rio de Janeiro 3
Salvador 3
The Bronx 3
Amsterdam 2
Baghdad 2
Bengaluru 2
Boston 2
Brooklyn 2
Bình Dương 2
Bắc Giang 2
Calgary 2
Cape Town 2
Curitiba 2
Denver 2
Dublin 2
Freiburg im Breisgau 2
Greensboro 2
Gwanak-gu 2
Jakarta 2
Kingston 2
Louisville 2
Miami 2
Milwaukee 2
Phoenix 2
Qingdao 2
Querétaro 2
Santa Rosa 2
Santo André 2
Seattle 2
Thái Nguyên 2
Wroclaw 2
Xi'an 2
Aligarh 1
Americana 1
Amman 1
Amorosi 1
Annapolis 1
Araripina 1
Araruama 1
Araxá 1
Araçuaí 1
Atsugi 1
Aurangabad 1
Auriflama 1
Aurora 1
Açailândia 1
Baguio City 1
Bagé 1
Totale 1.193
Nome #
Management of Psoriasis Patients with Serious Infectious Diseases 154
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 154
Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting 143
The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review 136
Corrigendum: A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab (Clin Cosmet Investig Dermatol. (2023), 16, (3503–3507), 10.2147/CCID.S447123) 132
Risk Factors for Psoriasis Flares: A Narrative Review 119
Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation 113
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials 112
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities 104
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond 103
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab 99
Effectiveness, Safety, and Long-Term Continuation Rate Analysis of Dupilumab Treatment in Adolescents with Atopic Dermatitis: A Single-Center Real-Life Retrospective Study 91
Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review 87
Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use 79
The emerging role of Bruton’s tyrosine kinase inhibition in urticaria management 76
Biologics and small molecules for psoriasis: current and future progress 45
The Use of JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Narrative Review of Clinical and Real-World Evidence 44
Efficacy and tolerability of bimekizumab within patients with moderate-to-severe plaque psoriasis: learnings from real world evidence 41
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study 30
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study 30
Head and Neck Dermatitis in Atopic Dermatitis: A Narrative Review of Pathogenesis, Clinical Challenges, and Therapeutic Strategies 26
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study 25
Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting—IL AD 24
Prevention and management of cutaneous immune‐related adverse events: EADV Task Force statement 21
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors 20
Letter: Atopic Dermatitis, 2-HEMA Allergic Contact Dermatitis, and Chemical Leukoderma: Which Relationship? 19
Real-Life Effectiveness, Safety, and Growth Outcomes of Dupilumab in Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis: A Multicenter Retrospective Study from an Italian NPP Program 1
Effectiveness of Baricitinib in Treating Atopic Dermatitis in Difficult-to-treat Areas: A Retrospective Real-world Study 1
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study 1
Totale 2.030
Categoria #
all - tutte 6.872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.872


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202459 0 4 18 1 0 3 1 2 0 4 11 15
2024/2025512 11 20 3 18 16 39 34 43 27 59 189 53
2025/20261.410 112 133 108 127 195 58 144 149 190 101 33 60
2026/202749 49 0 0 0 0 0 0 0 0 0 0 0
Totale 2.030